Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q4 2017 · 10-K
Revenue$228.07M$228.07M−5.9% vs Q4 2016 Net Income-$51.14M-$51.14MN/M vs Q4 2016 EPS Diluted-$0.98-$0.98N/M vs Q4 2016 Gross Profit$82,111,000−8.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$34,577,000−35.1% Free Cash Flowderived$18,959,000−23.3% Margins · derivedGross margin36.0%−0.8 pt vs Q4 2016
Operating margin-25.2%−22.9 pt vs Q4 2016
Net margin-22.4%−18.8 pt vs Q4 2016
ended Apr 1, 2017 · filed May 24, 2017 · 53 d after period end